Delivering mitochondrial health
On September 26 (Monday), 2022, Abliva will attend Aktiespararna's Aktiedagen Lund, at Elite Hotel Ideon. CEO Ellen Donnelly will present the company at 4 p.m. CEST. See below for more info and registration.
Abliva will attend the Nordic Life Science Days in Malmö, Sweden, on September 28-29, 2022. CEO Ellen Donnelly will be presenting the company at 11:00 CEST on Sep 29.
In October, Abliva will attend the Italian patient organization Mitocon's annual Mitochondrial Diseases Conference in Rome, Italy. On October 8, Abliva's Chief Medical Officer Magnus Hansson will give the talk: An adaptive, clinical Phase 2/3 study evaluating the efficacy of KL1333 in adult primary mitochondrial disease patients in Session 5: Challenges and pitfalls in clinical […]
Abliva will visit Aktiespararna Västra Blekinge/Bromölla in Olofström on November 8, 2022. Abliva's CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.
Abliva will come to Aktiespararna's local club Sydöstra Skåne, in Tommarp, Sweden, on November 17, 2022. Abliva’s CFO Catharina Johansson and Communications Officer Eleonor Åsander Frostner will be presenting the company during the evening. See below for more info and registration.
In late November, Abliva will attend the annual scientific conference Mitochondrial Medicine - Therapeutic Development in Hinxton, UK. Abliva's Chief Medical Officer, Magnus Hansson, will present a poster on one of the important preparatory studies for the upcoming, potentially registrational, Phase 2 study, FALCON, with KL1333 in patients with mitochondrial diseases.
In late November, Abliva will attend Aktiespararna's Stora Aktiedagen Stockholm. The company's CEO, Ellen Donnelly, will present the company via Zoom on November 29, 2022, at 7:30 p.m. CET. See below for detailed information and a link to the event.
In December 2022, Abliva will attend the 7th Annual Nordic American Life Science Conference, hosted by DNB, Nasdaq, and Business Sweden, in New York, US. Abliva's CEO Ellen Donnelly will present the company on December 8.
Abliva will attend the virtual BioStock Investor Meeting on March 16, 2023. CEO Ellen Donnelly will be presenting the company in BioStock's studio in Lund. The event will be broadcasted online on the BioStock website and YouTube channel.
We will digitally attend this year's BIO-Europe spring, hosted in Basel, Switzerland, on March 20 - 22, 2023. This major life science and biotech meeting offers a great opportunity for networking and partnering.
In April, we will attend this year's Kempen Life Science Conference in Amsterdam, Netherlands.
In mid-May, Abliva will attend and present at Bio€quity Europe 2023 in Dublin, Ireland. "For more than 20 years, Bio€quity Europe has been where CEOs and investors gather to network, partner and debate critical issues facing the biotech industry today." CEO Ellen Donnelly will present the company on May 15 during the session Other Approaches […]
